Prescription drug TIROSINT levothyroxine recalled for subpotent formulation
IBSA Pharma has recalled two lots of TIROSINT levothyroxine sodium oral solution nationwide because they contain less active ingredient than labeled. The affected lots are 220409 (expiring 10/2023) and 220956 (expiring 03/2024).
- Product
- TIROSINT — TIROSINT (LEVOTHYROXINE SODIUM)
- Category
- Drug
- Distribution
- Distributed nationwide